Adaptive Biotechnologies ADPT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's total equity?
- Adaptive Biotechnologies (ADPT) reported total equity of $216.34M in Q1 2026.
- How has Adaptive Biotechnologies's total equity changed year-over-year?
- Adaptive Biotechnologies's total equity increased by 13.6% year-over-year, from $190.42M to $216.34M.
- What is the long-term trend for Adaptive Biotechnologies's total equity?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's total equity has grown at a -21.7% compound annual growth rate (CAGR), from $743.27M to $218.79M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.